Erectile dysfunction occurs frequently in humans with diabetes mellitus; the molecular basis of this phenomenon is not known. We investigated the effects of diabetes on penile erection, nitric oxide synthase and growth factors expression in an animal model. Forty male rats were divided into two groups: the experimental group (n 30) received intraperitoneal injection of Streptozotocin (STZ) dissolved in citrate buffer to induce diabetes; ten age-matched control rats received injection of citrate buffer vehicle only. Before euthanization at eight weeks, erectile function was assessed by electrostimulation of the cavernous nerves. NADPH diaphorase staining was used to identify NOS and immunostaining technique was used to identify nNOS in the penile nerve ®bers. RT-PCR was used to identify mRNA expression of nNOS, eNOS, iNOS, ER-b b, ER-a, NGF, IGF-I, TGF-b1, and AR. Western blot was used to identify nNOS, IGF-I, NGF, and TFG-b protein expressions. In the diabetic group, there was: (1) a signi®cant decrease in NOS containing nerve ®bers in the dorsal and intracavernosal nerves; (2) a signi®cant lower maximal intracavernosal pressure. RT-PCR showed down-regulation of nNOS (large form), iNOS and ER-b mRNA expression, Immunoblot showed down-regulation of nNOS protein expression and nNOS immunostaining showed less positive staining in the dorsal and intracavernous nerves in the diabetic group. These molecular changes may provide the basis for further studies to explore the association between diabetes and impotence.
Introduction
Impotence is a common clinical problem in USA with tens of thousands of new cases per year. In the United States alone, approximately 20 million men suffer from erectile dysfunction due to various causes. Although the overall incidence of erectile dysfunction in the general population between the ages of 40 and 70 y is 52%, men with diabetes mellitus have impotence at an earlier age and with a signi®cantly higher prevalence, ranging as high as 75%. 1, 2 Sexual dysfunction is a known complication of diabetes mellitus and it is believed that diabetic neuropathy contributes to impotence. Psychological factors are important but the vast majority of diabetic patients have an organic basis for their impotence. Both neurogenic and vascular factors are important determinants in the pathogenesis of erectile failure. In the majority of these patients, abnormal smooth muscle responsiveness may be the underlying cause, leading to penile arterial insuf®-ciency and venous leakage. 3, 4 Erectile dysfunction occurs frequently in human diabetics as well as animals with spontaneous or druginduced diabetes. Vernet et al 5 reported that erectile dysfunction was encountered in all of type I and in most of type II diabetic rats. This was evidenced by over 95% decrease of erectile re¯exes in both types of diabetes. Both types of diabetes showed a marked decrease of penile NOS activity and a lower but signi®cant reduction of penile nNOS content.
Although several clinical and experimental studies had shown the vascular and neurological effects of diabetes on the erectile function, 6 ± 8 no study has explored the molecular basis of those effects. Our objective is to investigate the cellular and molecular mechanisms of impotence associated with diabetes, using an animal model.
Materials and methods

Experimental animals
Forty male Fischer 344 rats (aged 60 to 80 d and 150 ± 200 gmaeach), were divided into two groups: the experimental group (N 30) received intraperitoneal injection of 25 mgakg twice at two weeks interval of STZ dissolved in citrate buffer (100 mM citric acid, 200 mM di-sodium phosphate, pH 7.0) to induce diabetes; ten age-matched control rats received injection of citrate buffer vehicle only.
Functional evaluation and tissue procurement
Eight weeks after injections, rats in each group were explored for direct electrostimulation of the cavernous nerve before tissue collection. Under anesthesia with intraperitoneal pentobarbital sodium (35 mgakg), each animal was placed on a heating pad to maintain its body temperature at 37 C. PE-50 tubing was inserted into the left carotid artery via a midline neck incision to record the blood pressure. Through a lower abdominal midline incision, the area posterolateral to the prostate was explored on both sides and the major pelvic ganglions, the pelvic nerves and the cavernous nerves were identi®ed and exposed. Surgery was facilitated by an operating microscope (Olympus, 10 ± 40Â). The skin overlying the penis was incised and both penile crura were exposed by removing part of the overlying ischiocavernous muscle. A 23G needle ®lled with 250 Unitaml of heparin solution was connected to PE-50 tubing and was inserted in the right crus for the pressure measurement.
Electrostimulation was performed with a delicate stainless-steel bipolar hook electrode attached to a multi-jointed clamp, (each pole was 0.2 mm in diameter; the two poles were separated by 1 mm). Monophasic rectangular pulses were generated by Macintosh computer with a custom-built constant current ampli®er. Stimulus parameters were: current 1.5 mA, frequency 20 Hz, pulse with 0.2 m s, and duration 50 s. The cavernous nerve was stimulated on each side. Intracavernous pressure was measured and recorded with a Macintosh computer programmed with Lab VIEW 4.0 software, (National instruments, Austin, TX).
After the functional study was completed, a proximal penile segment was taken for staining of the cavernous tissue and dorsal nerve. The tissue collected was immediately placed in a ®xative. The distal end of each penile segment was marked with methylene blue to facilitate future orientation. A different penile segment was taken and kept in 770 freezer until it was processed for analyzing protein and mRNA expressions. Blood sample from each rat was drowning by direct suction from the heart and sent for serum glucose estimation.
NADPH-diaphorase staining
Before euthanization at eight weeks, erectile function was assessed by electrostimulation of the cavernous nerves. Nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase staining was used to identify NOS in the penile nerve ®bers of the proximal penile segment. Tissue specimens were ®xed for 4 h in a cold, freshly prepared solution of 2% formaldehyde, 0.002% picric acid in 0.1 M phosphate buffer, pH 8.0. Tissues were cryoprotected for 24 h in cold 15% sucrose in 0.1 M phosphate buffer, pH 8.0. They were then embedded in O.C.T. compound (Tissue-Tek, Miles Laboratory), frozen in liquid nitrogen, and stored at 770 C. Cryostat tissue sections were cut at 7 mm and adhered to charged slides, air-dried for 5 min, and hydrated for 10 min with 0.1 M PO 4 , pH 8.0. Sections were incubated with 0.1 mM NADPH, 0.2 mM nitroblue tetrazolium, 0.2% Triton X-100 in 0.1 M PO 4 , pH 8.0, for 60 min at room temperature. The reaction was terminated by washing sections in buffer. Slides were then coverslipped with buffered glycerin as the mounting medium. 9 The presence of NADPH diaphorase-positive nerves is easily apparent with this stain and is seen as a highly localized, densely blue region. The staining pattern was assessed by counting the number of NADPH-positive nerve ®bers present in four random ®elds (magni®cation 400Â) of the corpus cavernosum and in the entire dorsal nerve (endothelium staining was not included in the count).
Immunostaining
Immunostaining technique was used to identify nNOS. Frozen specimens were cut at 10 mm and the sections allowed to air dry for 30 min on SuperFros 1 slides. After rehydration with buffer (0.05 M PBS, pH 7.4) sections were treated with 0.3% hydrogen peroxide in methanol for 5 min to block endogenous peroxidase staining. Sections were rinsed with water, then buffer, followed by incubation in buffer with 3% goat serum for 4 h. Sections were incubated overnight with primary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at the following dilutions in PBSa3% goat serum: n-NOS, 1:2000 to 1:3000.
Sections were washed three times (®ve minutes each), and immunostained using the avidin-biotinperoxidase method (Elite ABC, Vector Laboratories, Burlingame, CA), with diaminobenzidine as the chromogen, followed by counterstaining with hematoxylin.
mRNA expression by differentiated RT-PCR
RT-PCR were used to identify mRNA expression of nNOS, ER-b NGF, IGF-I, TGF-b1, ER-a, and AR.
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RNA preparation
Freshly dissected corpus cavernosum was homogenized in Tri-Reagent RNA extraction solution (Molecular Research Center, Cincinnati, OH). Following the recommended procedure by the supplier, RNAs were further treated with DNAase I to remove traces of contaminating DNA. Integrity of RNAs was examined by agarose gel electrophoresis.
RT-PCR analysis
RT-PCR (reverse transcription-polymerase chain reaction) was performed in two steps: an initial RT step and a subsequent PCR step. In the RT step, the cellular mRNAs were reverse-transcribed into à library' of complementary DNAs (cDNAs). This cDNA library was then used for the analysis of expression patterns of various genes in the PCR step. The RT procedure was performed with the SuperScriptase reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD) and its accompanying reagents. Brie¯y, 2.5 mg of each tissue RNA was annealed to 0.4 mg of oligo-dT primer in a 12 ml volume. Four ml of 5Â buffer, 2 ml of 0.1 M DTT, 1 ml of 10 mM dNTP, and 1 ml of SuperScriptase were then added to bring the ®nal reaction volume to 20 ml. After one hour of incubation at 42 C, the RT mixture was incubated at 70 C for 10 min to inactivate the reverse transcriptase. Eighty ml of TE buffer was then added to make a 5Â diluted library. A portion of this library was further diluted to various concentrations (down to 1a100 dilution). One ml of each dilution was then used in a 10 ml PCR to identify the optimal input within the linear ampli®cation range. In addition to the 1 ml of diluted library, the PCR mixture contained 10 ng of each of a primer pair and reagents supplied with the Taq polymerase (Life Technologies, Inc., Gaithersburg, MD). PCR was performed in the DNA Engine thermocycler (MJ Research, Inc., Watertown, MA) under calculated temperature control. The cycling program was set for 37 cycles of 94 C, 5 s; 55 C, 5 s; 72 C, 10 s, followed by one cycle of 72 C, 5 min. The PCR product was electrophoresed in a 1.5% agarose gel, visualized by UV¯uorescence, and recorded by a digital camera connected to a computer. Densitometry was performed to determine the relative levels of gene expression, using the b-actin gene expression PCR result as a reference.
Design of olignucleotide primers
For RT-PCR analysis of mRNA expression of various genes (see Table) and for DNA sequence analysis of the RT-PCR products, we have designed and synthesized several pairs of oligonucleotide primers. The strategy for the design of these oligonucleotides includes the following considerations: (1) each primer is approximately 20 nucleotides in length with an optimal annealing temperature of 55 C; (2) each primer pair is designed to generate a speci®c RT-PCR product of approximately 500 bp; (3) to facilitate our studies on both rat models and human patients, our primers are derived from cDNA sequences that are completely identical in humans and rats; (4) to avoid the generation of PCR products from residual contaminating genomic DNAs, the two primers in each primer pair are selected from two separate exons whenever the gene structure information is available. 
Western blotting
The protein expression of nNOS, IGF-I, NGF, and TGF-b was studied using Western Blot technique. Cavernosal tissue from each rat was homogenized in phosphate buffer (10 mM phosphate buffer, pH 7.4; 150 mM NaCl; 1 mM phenylmethylsulfonyl¯uoride, 25 mgaml aprotinin, and 25 mgaml leupeptin). The homogenate was then centrifuged in eppendorf tubes at 10 000 RPM for 20 min at 4 C. The protein concentration in the supernatants was determined by the Lowry micro method.
Each sample was denatured for 5 min at 100 C in Laemmli sample buffer. Equal amounts of protein Diabetes-induced impotence: molecular mechanisms AI El-Sakka et al were loaded for each sample and electrophoretically separated on 16.5% SDS-PAGE and transferred to nitrocellulose membrane. The membrane was blocked with 0.2% casein and 0.1% Tween in 20 mM Tris saline buffer at pH 7.2. NOS subtypes were detected using speci®c primary antibodies (1:500 dilution) to these growth factors and alkaline phosphatase conjugated goat anti-rabbit secondary antibodies (1:20 000 dilution). The membrane was processed and treated with chemiluminescence reagents supplied by Tropix (Medford, MA). The bands were visualized on an x-ray ®lm exposed to the membrane to detect chemiluminescence signals.
Statistical analysis
Data were compared with Mann ± Whitney U-tests for unpaired samples with Statview 4.02 software. Values were considered signi®cant at P 0.05. Data is expressed as the mean AE s.e.m. unless otherwise stated.
Results
NADPH-diaphorase staining
Histological examination of proximal penile segment specimens revealed distinct NOS staining pattern in the dorsal nerve (Table 1 ) and intracavernous nerves (Table 2 ). In the diabetic group, the number of NOS-containing nerve ®bers was signi®-cantly less than the control group in both the dorsal and the cavernous nerves, P`0.05 ( Figures 1A, B  and 2A, B) .
Functional study
Electrostimulation of the cavernous nerve in the diabetic group elicited signi®cantly lower erectile response compared to the control group ( Figure 3A , B and Table 2 ). Moreover we noticed that the stimulation curve in the diabetic group is usually`s hort-lived' as it started after a relatively long latency period and the duration of the curve is short and pressure goes down to the base line before the end of stimulation.
Blood glucose analysis
The blood glucose level was signi®cantly higher in the diabetic-induced group (518 mgadl AE 18.9) than the control group (95 mgadl AE 4.1) Table 3 .
RT-PCR
There was signi®cant down-regulation of nNOS (large form), iNOS and ER-b mRNA expression in the diabetic group ( Figure 4A ± C) . There was no signi®cant differences in IGF-I, AR, NGF, TGF-b1, mRNA expression between diabetic and control groups ( Figure 4E ± G) . There was no expression of eNOS, or ER-a, in either the control or diabetic rats.
Western blot
Immunoblot revealed signi®cant down-regulation of nNOS protein expression in the diabetic group ( Figure 5 ). There was no signi®cant difference in protein expressions of IGF-I, NGF, or TGF-b1 between diabetic and control group.
Immunostaining
Immunostaining con®rmed the results of western blot and RT-PCR and showed less positive staining of nNOS in the dorsal ( Figure 6A , B) and intracavernosal ( Figure 7A, B) nerves of the diabetic group than the control group. 
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Discussion
Erectile dysfunction is a known complication in men with diabetes mellitus. Neurologic and vascular de®ciencies are the most commonly cited causes of the dysfunction. In human penile tissue obtained at the time of penile prosthesis insertion, Saenz de Tejada et al 10 has demonstrated that neurogenic and endothelium-dependent relaxation in diabetic cavernosal smooth muscle strips was impaired, while the response to direct smooth muscle relaxants, for example, papaverine, was not, suggesting that the NO pathway may be impaired while the effector organ is intact.
In spontaneous diabetic rats (BBaWORdp and BBZaWOR), Vernet et al 5 reported a 95% decrease in erectile re¯exes, 75% decrease in serum testosterone, marked decrease in penile nNOS activity (by [3H]-L-arginineacitrulline conversion assay) and reduction of penile nNOS content (by western blot).
On the other hand, in streptozotocin-induced diabetic rats, Elabbady et al 11 reported a deterioration of all erectile parameters, while the NOS activity (also by [3H]-L-arginineacitrulline conversion assay) in penile tissues was signi®cantly higher than that in control rats.
Our results in streptozotocin-induced diabetic rats clearly showed: (1) a decreased gene expression of nNOS, iNOS; (2) a decreased protein expression of nNOS; and (3) a decreased NADPH-diaphorase staining and nNOS immunostaining of the dorsal and intracavernous nerve ®bers. These ®ndings correlate well with the functional study which Diabetes-induced impotence: molecular mechanisms AI El-Sakka et al Diabetes-induced impotence: molecular mechanisms AI El-Sakka et al showed a decreased erectile response to electrical stimulation of the cavernous nerves. Our results agree with the report by Vernet et al 5 and suggest a decrease nNOS expression may be responsible for neurogenic erectile dysfunction in diabetic rats. We also noted a decrease in iNOS expression. Since we could not obtain gene expression of eNOS, we are unable to explain the increased NOS activity as reported by Elabbady et al. 11 In addition, since both the gene and protein expression of penile nNOS are decreased in diabetic rats, it is likely that the effect of diabetes is at the transcription level rather than at the translation level. Further studies are needed to elucidate the mechanism.
Recently, two isoforms of nNOS have been reported. 12, 13 We have found that these two isoforms exist in different proportions in the lower urinary tract, skeletal muscle and the penis. In this study, we found a signi®cant down-regulation of only the large form of nNOS in the diabetic rats but not the small form. This is a very interesting ®nding and its signi®cance is yet to be explored. 
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It is also possible that the reduction of nNOS in the diabetic penis may be due to autonomic neuropathy or vascular insuf®ciency. In diabetic human penile tissue, denuded sinusoidal endothelium lining, axon degeneration and smooth muscle atrophy have been observed.
14 Although we did not see any electron microscopic evidence of nerve degeneration or microvascular disease in our animals (data not shown), theoretically, these changes may occur if the rats are kept for longer periods of time.
Recently, Rehman et al 8 examined the effects of diabetes on erectile function in rats. They found that the intracavernous pressure responses to neurostimulation was signi®cantly attenuated in both STZ-diabetic and subtotal pancreatectomy animals compared to age-matched control animals. This attenuation of intracavernous pressure was strongly correlated with diminished synaptophysin immunoreactivity in the corpora. Northern analysis revealed a marked diabetes-related increase in the amount of connexin 43 mRNA in corporal tissue. This implies that impairment of intercellular communication among intracavernous smooth muscle cells may also contribute to erectile dysfunction. In addition, Autieri et al 15 reported that cultured smooth muscle cells from corpus cavernosum of diabetic patients display signi®cantly altered K channel function, PGE-induced cAMP accumulation, and endothelin-1 induced Ca2 mobilization. Therefore, it is reasonable to assume that diabetes can have multiple effects on the erectile tissue.
The Streptozotocin-induced diabetic rats were often reported to develop weight loss, liver toxicity Diabetes-induced impotence: molecular mechanisms AI El-Sakka et al and tumors. 16 These effects have not hindered the usefulness of using this animal model in many studies. With our modi®cation of injecting 25 mgakg streptozotocin twice at a two week interval, the rats used in our study were not as sick as those described in previous reports. Our method, therefore, appears to be better in inducing diabetes in rats.
Although the neurological and vascular effects of diabetes have been studied extensively in human and animal models, very little is known about the molecular bases of these effects. In general, growth factors are multifunctional modulators of physiologic and pathologic processes such as cellular growth, embryogenesis, wound healing and carcinogenesis. 17 Growth factors function by binding to speci®c cell surface receptors that are composed of three distinct regions or domains: an extracellular domain, which binds to the growth factor ligand; a transmembrane domain; and an intracellular domain. 18 NGF was initially described as a peptide growth factor which led to massive and profuse growth of sensory and sympathetic nerves and cause hypertrophy of the associated ganglia. 19 NGF is a neurotrophic protein that supports the survival and differentiation of sympathetic and primary sensory neurons. 20 Despite the abundance of data on the role of NGF and its receptors in the injured nervous system, little is known about the exact function of the endogenous NGF in nerve regeneration.
Insulin-like growth factors (IGFs) are a single chain polypeptides with structural homology to proinsulin. They regulate proliferation and differentiation of a multitude of cell types and are capable of exerting insulin-like metabolic effects. Part of the allure of IGF-I as a therapeutic agent is its wide range of biological effects and its actions on many different tissues. IGF-I mediates many, if not most of the anabolic effects of circulating growth hormone. It stimulates bone formation, protein synthesis, glucose uptake in muscle, and myelin synthesis. Recently, growth hormone has been found to enhance regeneration of nitric oxide synthasecontaining penile nerves after cavernous nerve neurotomy in rats. 21 Growth hormone is known to stimulate hepatic production of IGF-I which is the mediator of most of growth hormone functions. Weiss et al 22 showed a transient increase in IGF-I in a diabetic rat model followed by rapid renal hypertrophy and constant renal hyperperfusion, however renal IGF-I levels returned to normal within four days. Also, they showed the IGF-I mRNA level in the chronically diabetic kidney was approximately 50% of that of the control rats, whereas IGF-I receptors mRNA increased approximately three fold.
The peptide TGF-b 1 was isolated from human platelets, human placenta, and bovine kidney and was characterized as a discrete molecular entity, namely a 25 kD homodimer with a unique NH 2 -terminal sequence. 23 The role of TGF-b is involved in numerous vital processes including in¯amma-tion, stimulation of intercellular matrix formation, production of ®broblasts, and normal healing. 24 While growing evidence implicates TGF-b as a cytokine, vital to tissue repair, its excessive action may be responsible for tissue damage caused by scarring in many serious diseases. The pathological consequences of the action of TGF-b have been referred to as the`dark side' of tissue repair. 25 In this study, we did not see signi®cant changes of NGF, IGF-I and TGF-b1 in the penile tissue of diabetic rats as compared with the controls. However, changes of other growth factors may occur and study of several other growth factors will be the subject of a future study.
Androgen activity is mediated by a high-af®nity androgen receptor (AR). Clinical syndromes of androgen resistance resulting from molecular defects in the human androgen receptor gene encompass a wide range of abnormalities in male sexual development and function. Although Vernet et al 5 showed a decrease of testosterone level in their spontaneous diabetic rats, our study did not show a change of androgen receptor gene expression in diabetic rats.
Estrogen in¯uences growth, differentiation and functioning of many target tissues. These include tissues of male and female reproductive systems, such as mammary gland, uterus, vagina, ovary, testis, epididymis and prostate. 26 Estrogens are mainly produced in ovaries and testis. They diffuse in and out of cells, but are retained with high af®nity and speci®city in target cells by an intranuclear binding protein, termed the estrogen receptors. Once bound by estrogens, the ER undergoes a conformational change allowing the receptors to interact with high af®nity with chromatin and to modulate transcription of target genes. 27 ± 29 The ER is a member of the nuclear receptor superfamily which consists of a surprisingly large number of genes. 28 In 1995, a novel estrogen receptor (ER-b) was cloned from a rat prostate. 30 The ER-b subtype protein is highly homologous to the presently known estrogen receptor protein (ER-a), particularly in the DNA-binding domain and in the ligandbinding domain. The relative level of ER-a and ER-b mRNA expressions in various rat tissues is quite different; that is, moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, adrenal for ER-a and prostate, ovary, lung, bladder, brain, testis, for ER-b. 26 The recent discovery that estrogen receptor subtype beta is present in various rat, mouse and human tissues has advanced signi®cantly our understanding of the mechanisms underlying estrogen signalling. It suggests the existence of two previously unrecognized pathways of estrogen signalling; via ER-b in cells exclusively Diabetes-induced impotence: molecular mechanisms AI El-Sakka et al expressing this subtype and via the formation of heterodimers in cells expressing both ER subtypes. To our knowledge our study is the ®rst one to describe the presence of ER-b in the penile tissue. Although we found signi®cant down-regulation of ER-b mRNA in the penile tissue of diabetic rat, its signi®cance in erectile dysfunction is unknown.
Conclusions
The results showed that erectile function and NOS containing nerve ®bers in the dorsal and intracavernous nerves were decreased in the diabetic rats. Signi®cant changes were associated with differential gene and protein expression of nNOS, and gene expression of iNOS and ER-b. This knowledge may provide the basis for future studies to explore the molecular mechanism of erectile dysfunction associated with diabetes.
